Cough syrup contaminated with DEG has caused ARI and the death of many children in The Gambia.

Published Date: 06 Mar 2023

USA: The syrup drug Diethylene glycol (DEG), a drug commonly used to prevent infections, is the cause of kidney disease...

Read Full News

Latest News

Would Earlier Initiation of Clozapine Improve FEP Outcomes?

Higher response rates with clozapine after a single treatment failure raise questions about current recommendations and whether it should be used earlier in first-episode psychosis.

Hidden Bacteria Found in Common Kidney Stones

Researchers identify live bacteria within calcium kidney stones, raising new questions about stone formation and suggesting new targets for prevention and treatment.

Showing Future Heart Risks Visually Helps Patients Manage BP

Adding a tool that shows patients their 5-year risk for heart disease, along with monthly emails, may help manage blood pressure and cholesterol in people with hypertension, a trial shows.

Cardiometabolic Control Elusive in Adults With Hypertension

Despite new therapies, metabolic risk hasn’t improved in more than a decade.

Low eGFR Not Associated With DKA Risk in T1D

A new study supports the use of kidney-protective medication for patients with type 1 diabetes.

Super-Resolution Ultrasound Can Track Early Kidney Disease

Noninvasive ultrasound localization microscopy-based assessment of intrarenal microvasculature can reveal microvascular abnormalities at an early stage in individuals with polycystic kidney disease.

Todays Updates

Can Oncotype Predict Recurrence Risk in Older BC Patients?

A recent study assesses whether Oncotype DX can predict local recurrence risk in older, lower-risk patients with breast cancer who omit adjuvant radiation.

Todays Updates

Can Oncotype Predict Recurrence Risk in Older BC Patients?

A recent study assesses whether Oncotype DX can predict local recurrence risk in older, lower-risk patients with breast cancer who omit adjuvant radiation.

Latest News

Higher response rates with clozapine after a single treatment failure raise questions about current recommendations and whether it should be used earlier in first-episode psychosis.

Researchers identify live bacteria within calcium kidney stones, raising new questions about stone formation and suggesting new targets for prevention and treatment.

Adding a tool that shows patients their 5-year risk for heart disease, along with monthly emails, may help manage blood pressure and cholesterol in people with hypertension, a trial shows.

Despite new therapies, metabolic risk hasn’t improved in more than a decade.

A new study supports the use of kidney-protective medication for patients with type 1 diabetes.

Noninvasive ultrasound localization microscopy-based assessment of intrarenal microvasculature can reveal microvascular abnormalities at an early stage in individuals with polycystic kidney disease.

News All Time

Younger Adults Face Pronounced Racial, Ethnic Gaps in Kidney Therapy

Younger Adults Face Pronounced Racial, Ethnic Gaps in Kidney Therapy

New MERD Risk Score Predicts Mortality for Kidney Transplant Waitlist Patients

New MERD Risk Score Predicts Mortality for Kidney Transplant Waitlist Patients

Gentamicin May Not Reduce Post Kidney Transplant Urinary Tract Infection Risk

Gentamicin May Not Reduce Post Kidney Transplant Urinary Tract Infection Risk

FDA Extends Sparsentan (Filspari) sNDA Review for Focal Segmental Glomerulosclerosis

FDA Extends Sparsentan (Filspari) sNDA Review for Focal Segmental Glomerulosclerosis

Elevated BMI and Physical Inactivity Drive Rising Global Hypertension-CKD Burden

Elevated BMI and Physical Inactivity Drive Rising Global Hypertension-CKD Burden

Malnutrition Reverses Obesity Survival Advantage in Hospitalized Patients With End Stage Kidney Disease

Malnutrition Reverses Obesity Survival Advantage in Hospitalized Patients With End Stage Kidney Disease

AI-Based ZEBRA Model May Improve Detection of Fabry Nephropathy on Kidney Biopsy

AI-Based ZEBRA Model May Improve Detection of Fabry Nephropathy on Kidney Biopsy

Low Exercise Tolerance Before Kidney Transplant Signals Poor Muscle Recovery

Low Exercise Tolerance Before Kidney Transplant Signals Poor Muscle Recovery

Diabetes, Anuria May Predict High Postvoid Residual After Kidney Transplantation

Diabetes, Anuria May Predict High Postvoid Residual After Kidney Transplantation

Global CKD Burden Projected to Rise in Young Adults and Decline in Children by 2050

Global CKD Burden Projected to Rise in Young Adults and Decline in Children by 2050

Depression's Implied Bilateral Link With Chronic Kidney Disease Progression

Depression's Implied Bilateral Link With Chronic Kidney Disease Progression

Young Adults With Glomerular Disease May Require Distinct Care

Young Adults With Glomerular Disease May Require Distinct Care

Q4 2025 Recap: Nephrology News and Updates

Q4 2025 Recap: Nephrology News and Updates

Serum Creatinine Trajectories May Predict 28-Day Mortality in CKD

Serum Creatinine Trajectories May Predict 28-Day Mortality in CKD

FDA Grants Priority Review Of Biologics License Application For Atacicept In IgA Nephropathy

FDA Grants Priority Review Of Biologics License Application For Atacicept In IgA Nephropathy

KDIGO Releases New Guideline for Anemia in Chronic Kidney Disease

KDIGO Releases New Guideline for Anemia in Chronic Kidney Disease

Recommended News For You

Analysis of projected cancer rates in Canada by 2024.

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

Citing a cancer risk, the EPA sets a new limit on medical sterilization chemicals.

Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.

Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.

GLP-1 receptor agonists show anti-cancer benefits beyond weight loss

Applications are being accepted for TN Health's post-doctoral fellowship program in gynecologic oncology and minimal access surgery; complete details are available here.

Recommended Articles For You

Understanding the Importance of CA125: A Comprehensive Guide  

Emerging Therapies and Technologies Reshaping Oncology: Innovations and Impact in 2025 

AI in the War on Cancer: How Digital Tools are Revolutionizing Oncology 

Exploring the Pleomorphic Adenoma: A Unique and Varied Tumor 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

ASCO: Vepdegestrant ups survival in ER+, HER2− advanced breast cancer with ESR1 mutations

2.

In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.

3.

One possible target in acute myeloid leukemia is the reductive carboxylation of glutamine.

4.

Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.

5.

Mapping lifelong chronic health risks for childhood cancer survivors

1.

Bridging Disciplines: Medical Oncology vs Surgical Oncology in the Era of Multidisciplinary Cancer Care

2.

A Comprehensive Guide to Living with Cutaneous T Cell Lymphoma: Tips & Strategies 

3.

Circulating Tumor Cells & Platelet Interactions: Crosstalk for Therapeutic Advances

4.

IL1R2 Inhibition: A New Strategy to Boost Cancer Immunity

5.

Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

3.

Efficient Management of First line ALK-rearranged NSCLC - Part VII

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I

5.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot